2,5,8,11,14,17,20-Heptaoxatricos-22-yne

Catalog No. :
ACPJMR758
CAS No. :
1101668-44-3
Molecular Formula :
C16H30O7
Molecular Weight :
334.41

IUPAC Name:2,5,8,11,14,17,20-heptaoxatricos-22-yne

2,5,8,11,14,17,20-Heptaoxatricos-22-yne structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$122.00Login to see priceIn stockInquiry
100mg95%$199.00Login to see priceIn stockIn stock
250mg95%$349.00Login to see priceIn stockIn stock
1g95%$882.00Login to see priceIn stockIn stock
5g95%$3556.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5,8,11,14,17,20-Heptaoxatricos-22-yne
IUPAC Name2,5,8,11,14,17,20-heptaoxatricos-22-yne
MDL No.MFCD31656934
Molecular FormulaC16H30O7
Molecular Weight334.41
SMILESCOCCOCCOCCOCCOCCOCCOCC#C
InChI KeyGBKVTPUSHXYSNK-UHFFFAOYSA-N
SynonymmPEG6-Propyne;m-PEG7-Propargyl;mPEG6-Propyne/2,5,8,11,14,17,20-Heptaoxatricos-22-yne;2,5,8,11,14,17,20-Heptaoxatricos-22-yne
CAS No.1101668-44-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H227-H315-H319
Precautionary Statement(s)
P210-P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P370+P378-P501

Synthetic Route by SureRoute

1. ACPJMR758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTNIE421 route compound structure diagram
    ACTNIE42123601-40-3 In Stock
  4. Then
  5. ACPJMR758 route product structure diagram
    ACPJMR7581101668-44-3 In Stock
Inquiry

2. ACPJMR758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACULGO472 route compound structure diagram
    ACULGO47223778-52-1 In Stock
  4. Then
  5. ACPJMR758 route product structure diagram
    ACPJMR7581101668-44-3 In Stock
Inquiry

Comments (0)